The abstract is read at the publisher; the summary is JClub's.
NF1-involving 17q11.2 microduplications show NDD/neurobehavioral disorders in 85% of 37 reported individuals, with developmental delay at 85% and autism spectrum disorder at 29%.
- Why it matters: NF1 microdeletion syndrome is well described, but the reciprocal NF1 microduplication has been unclear, limiting recognition and genetic counseling for neurodevelopmental risk.
- What they did: A scoping review of 14 studies extracted clinical and molecular data from individuals with 17q11.2 microduplications involving NF1, and DECIPHER was queried using identical criteria with Bayesian recalculation of NDD penetrance.
- The result: NDD penetrance estimates (25–40%) were lower than a previously reported 74%, and growth findings partially mirrored deletion features, supporting moderate-penetrance neurodevelopmental-susceptibility rather than a distinct syndrome.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.